“Limited Potential for Growth through Domestic Business Alone” Is Reason for Acquiring US Generic Maker: Nichi-Iko Pres.

Nichi-Iko President Yuichi Tamura Nichi-Iko Pharmaceutical President Yuichi Tamura said on July 12 that Nichi-Iko decided to acquire Sagent Pharmaceuticals of the US because: “Pressure on profits is expected in Japan’s generic drug market even if the generics’ share of...read more